Navigation Links
The Centers For Medicare and Medicaid Services Issues Advance Guidance to Part D Plan Sponsors Allowing the Use of Generic Sampling as Medicare Part D Drug Utilization Management Tool.
Date:3/10/2011

SAN DIEGO, March 10, 2011 /PRNewswire/ -- MedVantx, Inc., the company that created first ever controlled access to generic samples in US physician offices, today announced that the Centers For Medicare and Medicaid Services ("CMS") has issued preliminary guidance to Medicare Part D Plan Sponsors on generic sampling programs. In a February 11, 2011 advanced notice for public comment, CMS indicated that a Part D sponsor may incur expenses related to distribution of and reporting on generic drug samples, provided to members within a physician's office setting, under the plan's administrative cost structure.  Once this proposal is finalized, Part D plan sponsors may account for MedVantx's generic sampling program both in their 2012 Medicare offering and in the current year.

MedVantx provides free generic medications in US physician offices for consumers through its proprietary automated ATM-like prescription management system (MedStart™). The MedStart™ system automates the traditional pharmaceutical sampling process for the physician and the MedVantx Patient ProfileLink™ interface captures physician sampling data in the patient's health plan electronic medical record claims history. Through the MedVantx program, patients managing complex and chronic conditions can receive generic samples covering the majority of acute and chronic conditions as part of their physician office visit. MedVantx collaborates with physicians and health plans to provide consumers access to integrated care coordination management and reimbursement counseling services and the convenience of home delivery of low cost prescriptions.  The program has proven effective in reducing costs and critical gaps in care for patients with chronic and complex diseases.

"We are excited about the use of the MedVantx ProfileLink™ claims data in the Medicare Part D marketplace," said Susan Hogue, RPh, and MedVantx Director of Managed Networks & Clinical Services. "As the US prescription drug marketplace continues its rapid shift to low cost generics and consumerism, the ability to capture claims data on generic sample utilization at the point of care will help insure the clinical integrity of a Part D plan sponsor's pharmacy database."

In the advance notice, CMS also recognized that generic sampling could be an effective tool to promote compliance with drug therapy and lower costs for Medicare and reduce beneficiary copayments.  "By facilitating access to trial supplies of less costly generic versions of Part D drugs, plan sponsors can enhance their enrollees experience in Part D by reducing their current and future cost sharing expenses.  In the case of low income beneficiaries, facilitating medication starts on generic versions of drugs also helps to limit federal low income costs sharing subsidy requirements and overall program costs for the Medicare Trust Fund."  

"Traditional pharmaceutical cost management approaches have been maximized and Part D plan sponsors are seeking new tools to engage and influence physician and consumer behavior at the point of care," stated Robert Feeney, Chief Executive Officer of MedVantx. "The MedVantx physician network has helped over 2M patients start on generic therapy at the point of care and we are excited about the potential use of the MedVantx platform in the Part D marketplace," added Mr. Feeney.

Information regarding the Advanced Notification Guidance from The Centers For Medicare and Medicaid Services web site at www.cms.gov/PrescriptionDrugCovContra/Downloads/2011CombinedCallLetter.pdfAbout MedVantx, Inc.MedVantx is an innovative consumer medication management and delivery company committed to streamlining access, reducing costs and providing highly relevant information to benefit patients, physicians, health plans and manufacturers.  The MedVantx platform is a fully automated / integrated point of care to consumer home delivery channel focused on increasing the quality and cost effectiveness of the last non-managed pharmaceutical channel - the physician's office sample closet.  The Company's consumer medication management platform includes free initial prescription and over-the-counter medication therapy at the point of care; a consumer helpline providing drug information and reimbursement assistance and convenient consumer home delivery through its mail order pharmacy. The national MedVantx network has served over 2 million consumers through an integrated network including 16 health plans, 18 manufacturers and more than 3,600 prescribers.

For additional information about MedVantx and opportunities to participate in MedVantx Network, please contact MedVantx, Inc. at (858) 625-2990.MedVantx Contact:Susan Hogue(858) 625-2990 Ext. 142susan.hogue@medvantx.com
'/>"/>

SOURCE MedVantx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Anesthesiologists Use Caldolor® To Provide Preemptive Pain Control for Surgical Patients at U.S. Medical Centers
2. Papastavros Opens New Radiology Centers in Delaware
3. Astrum Hearing Inc. Is Not Affiliated with Astrum Hearing Aid Centers or Astrum Marketing
4. CyberKnife Centers of Miami and Palm Beach Announce New Chief Operating Officer
5. Cancer Treatment Centers Oncology Information System Options Expand with New MOSAIQ Connectivity
6. NeurogesX Receives Qutenza®-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
7. Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco
8. Seven U.S. Medical Centers Commence Study to Change Femoral Artery Cath Lab Access with the First Alternative to the Seldinger Technique in 51 Years
9. CURE Foundation Selects Varian Medical Systems to Supply Radiotherapy Technology for Five New Cancer Centers
10. Fenwal Named Exclusive Provider of AccuVeins Award-Winning Vein Illumination Device for Blood and Plasma Centers
11. Prenatal Imaging Centers, LLC Finds the 3D/4D Keepsake Exam an Opportunity to Screen Pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2017)... ORLANDO, Fla. , July 17, 2017  MedX ... - branded medical testing, strengthening and rehabilitation equipment, today ... Back Machine Program. MedX is considered the gold standard ... world leader in specialized medical strengthening equipment. ... into a lease with the physician or practice who ...
(Date:7/13/2017)... 2017  Centurion Medical Products, a leader in medical product innovation ... impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part of ... patient pain while preventing unneeded emergency department admission due to severe ...
(Date:7/12/2017)... , July 12, 2017  Eli Lilly and Company ... agreement with generic companies to resolve pending patent litigation in ... Virginia regarding the Cialis ® (tadalafil) ... on April 26, 2020. As part of the agreement, Cialis ... September 27, 2018. "The unit dose patent for ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... The Bryant Agency, a ... and business owners in the Dalton region, is working in conjunction with the ... assault and physical abuse. , The GreenHouse is headquartered in Dalton and provides ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... financial planning services to communities in the greater Birmingham area, is joining the ... to underprivileged young people in the region. , The Chris Hammond Youth Foundation ...
(Date:7/21/2017)... Norwalk, Connecticut (PRWEB) , ... July 21, 2017 , ... ... data from HealthCareMandA.com . The number of hospital acquisitions rose to 23 in ... quarter of 2017, and up 15% from the 20 announced deals in the year-ago ...
(Date:7/21/2017)... Basking Ridge, NJ (PRWEB) , ... July 21, ... ... Hills (VNA) has received a $5,000 grant from the C. R. ... Adult Day Center at Somerset Hills , a service available through the ...
(Date:7/21/2017)... Fresno, CA (PRWEB) , ... July 21, 2017 , ... ... Ms. “Tu” Tuantu Doan Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join ... than 27 years of experience in dermatology, skin cancer , and more. She ...
Breaking Medicine News(10 mins):